Registry of stenting procedures for coronary bifurcation lesions
International Prospective Register on Treatment of Coronary Artery Bifurcation Lesions
This study is collecting information on how well stenting works for patients with specific heart artery blockages to see what happens to them over five years.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 5000 (estimated) |
| Ages | 18 Years to 100 Years |
| Sex | All |
| Sponsor | Meshalkin Research Institute of Pathology of Circulation Research network |
| Locations | 1 site (Novosibirsk, Novosibirsk Oblast) |
| Trial ID | NCT03450577 on ClinicalTrials.gov |
What this trial studies
The International Bifurcation Study is an observational registry that collects real-world data on stenting procedures for patients with coronary bifurcation lesions. It aims to analyze long-term clinical outcomes and identify predictors of adverse events following percutaneous coronary intervention (PCI). Patients who meet the inclusion criteria will undergo PCI according to standard care and will be monitored for five years. This multi-center approach allows for a comprehensive understanding of treatment effectiveness across various healthcare settings.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and older with any type of bifurcation lesion in a major epicardial artery.
Not a fit: Patients who refuse to provide informed consent will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could improve treatment strategies and outcomes for patients with coronary bifurcation lesions.
How similar studies have performed: Other studies have shown success in similar observational approaches, indicating the potential for valuable insights from this registry.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥ 18 years * Any type of bifurcation lesion in major epicardial artery Exclusion Criteria: * Patient refused informed consent to participate in the registry
Where this trial is running
Novosibirsk, Novosibirsk Oblast
- Meshalkin National Research Center — Novosibirsk, Novosibirsk Oblast, Russia (Recruiting)
Study contacts
- Principal investigator: Dmitrii Khelimskii, MD — Meshalkin National Medical Research Center
- Study coordinator: Dmitrii Khelimskii, MD
- Email: dkhelim@mail.ru
- Phone: +79137069256
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.